Suzhou Zelgen Biopharmaceuticals Co. Ltd. Class ASSE: 688266

Announcement on Voluntary Disclosure of the Conduct of Key Clinical Trials for ZG006 for Injection and Completion of the Enrollment of the First Subject

· Issued by Suzhou Zelgen Biopharmaceuticals Co. Ltd. Class A via Shanghai Stock Exchange
Announcement on Voluntary Disclosure of the Conduct of Key Clinical Trials for ZG006 for Injection and Completion of the Enrollment of the First Subject

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis